From scrutiny of the U.S. healthcare sector to heightened antimonopoly compliance in China and voluntary disclosure incentives in Brazil, a new analysis from the Policy and Regulatory Report entitled "2013 Global Antitrust Trends" [PDF] examines how regulators around the world are tackling antitrust enforcement.
In the U.S., authorities at the Federal Trade Commission and the Department of Justice will continue their focus on competition as it relates to price and quality in the healthcare space, according to the report. "There was a flurry of filings in the fourth quarter of last calendar year," Rich Feinstein, the FTC’s top competition enforcement official, told PaRR. "There are plenty of things we’re looking at."
